A carregar...

Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease

OBJECTIVE: To determine whether patients randomized to unapproved, disease-modifying interventions in neurodegenerative disease trials have better outcomes than patients randomized to placebo by performing a systematic review and meta-analysis of risk and benefit experienced by patients in randomize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Feustel, Aden C., MacPherson, Amanda, Fergusson, Dean A., Kieburtz, Karl, Kimmelman, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011691/
https://ncbi.nlm.nih.gov/pubmed/31792092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008699
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!